Glaukos CorpGKOS
Price$163.17

Financial Snapshot

Revenue, profitability, returns, debt, and capital allocation

Revenue $612.8M+59.8% YoYTTM through 30 Jun 2026
Net Income -$188MTTM through 30 Jun 2026
Free Cash Flow -$12.2MTTM through 30 Jun 2026

Margins

Current
Gross Margin77.9%
EBITDA Margin-24.7%
Operating Margin-13.2%
Net Margin-30.7%

Returns

-28.2%ROE
-21.2%ROA

Balance Sheet Health

Debt / Equity0.00x
Current Ratio5.43x
Net Debt-$276.7Mnet cash position
Cash & Equivalents$114.5M

Quality Metrics

Altman Z-Score22.80
Piotroski F-Score2 / 9
FCF Margin-2.0%
Rule of 4010.7
Earnings-Beat Rate75.0%

Multi-Year Trend

Revenue
'19'20'21'22'23'24'25
FY2025: $507.4M
Diluted EPS-$3.27TTM
'19'20'21'22'23'24'25
FY2025: $-3.28

Dividend

No dividend

Capital Allocation

Capex Intensity1.8%
All values are periodic snapshots, not live quotes. Source dates are shown for reference.

Filing Detail Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up
AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.